Maximillian Mpina

In the News

This content is password protected. To view it please enter your password below:

Announcement: Provision of goods and services to IHI in 2019/20

(Dar es Salaam) IHI invites applications from eligible, competent and qualified companies for the prequalification to provide goods and services for the 2019/2020 financial year. Learn more about this here: …

Recent Projects

Calcium supplementation on pregnant women

Project summary This is a trial-based study funded by the Bill and Melinda Gates Foundation. It intends to generate evidence for decision-making on the potential non-inferiority of a lower dose …

Sustainable, Healthy, Learning Cities and Neighbourhoods

The Sustainable, Healthy, Learning Cities and Neighbourhoods is an exciting project in which IHI works with a consortium of partners from Asia and Africa to 1) develop capacity for improved …

Maximillian Mpina

Research Scientist and Head of IHI Laboratories

Dr. Maxmillian Mpina started his scientific career as a research officer at Ifakara Health Institute in 2007, with Bachelor of Science in Biotechnology and Laboratory sciences from Sokoine University of Agriculture, Tanzania. In 2011, he received his Master of Science in infection biology and epidemiology from Swiss Tropical and Public Health Institute, University of Basel, Switzerland. He received his PhD in 2016 also from Swiss Tropical and Public Health Institute, University of Basel, Switzerland. His PhD research focused on evaluating malaria specific immune responses induced by subunit vaccines (RTS, S) and controlled human malaria infections of semi immune populations. Dr. Mpina’s current research concentrates on understanding the cellular and humoral basis of vaccine induced and naturally acquired immunity, in particular the generation and maintenance of antigen-specific memory B and T cells against tropical infectious diseases such as malaria, TB and HIV. He’s currently also the Head of IHI Laboratories

View Dr. Mpina’s Research Interests and Publications


Evaluation of whole sporozoite vaccines for malaria elimination

© Ifakara Health Institute (IHI), 2016